Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antiviral drug |
| gptkbp:ATCCode |
gptkb:P01BA06
|
| gptkbp:CASNumber |
86-42-0
|
| gptkbp:category |
gptkb:4-aminoquinoline
phenol |
| gptkbp:chemicalFormula |
C20H22ClN3O
|
| gptkbp:discoveredIn |
1948
|
| gptkbp:eliminationHalfLife |
5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
amodiaquine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits hemozoin formation
|
| gptkbp:meltingPoint |
158-160°C
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
gptkb:DB00613
2165 |
| gptkbp:relatedTo |
chloroquine
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting hepatotoxicity agranulocytosis |
| gptkbp:synonym |
gptkb:Camoquin
gptkb:Flavoquine |
| gptkbp:UNII |
KQ9U09EVR6
|
| gptkbp:usedFor |
gptkb:artesunate
treatment of malaria |
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:CYP2C8
gptkb:Malaria_Consortium's_SMC_program gptkb:artesunate gptkb:sulfadoxine-pyrimethamine |
| gptkbp:bfsLayer |
6
|